JI
Sen. James Inhofe (R-OK) bought $15K-$50K of NTLA stock
James Inhofe, U.S. Senator (R-OK), disclosed a purchase of Intellia Therapeutics Inc. (NTLA) stock worth $15K-$50K in a STOCK Act filing on Nov 8, 2017.
The trade happened on Oct 19, 2017, 20 days before it was made public.
NTLA has moved -59.3% since the trade date, from $28.05 to $11.41 (Nov 11, 2026 close).
- Traded
- Oct 19, 2017
- Disclosed
- Nov 8, 2017
- Filing delay
- 20 days
- Price since
- -59.3%
- Source
- STOCK Act disclosure